Dukemount Capital Plc
12 October 2022
Dukemount Capital Plc ("Dukemount" or the "Company") Issue of Equity
Further to its announcement of 10 October 2022 regarding further funding and funding restructuring, Dukemount Capital Plc, has issued 74,575,000 ordinary shares to settle a 9.5% extension fee of £74,575 to its existing Noteholders.
When issued, the New Shares will be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares in the share capital of the Company, including the right to receive all dividends and other distributions declared, made or paid on or in respect of such shares after the date of issue of the New Shares.
Application has been made to the Financial Conduct Authority ("FCA") for admission of the New Shares to the standard listing segment of the Official List and to the London Stock Exchange (the "LSE") for admission to trading of the New Shares on the LSE's Main Market for listed securities (together "Admission"). It is expected that Admission will take place at 8 a.m. on or around 17 October 2022 and that dealings in the New Shares on the LSE's main market for listed securities will commence at the same time.
Total Voting Rights
The Company does not hold any Ordinary Shares in treasury. Therefore, following Admission, the total number of voting rights in Dukemount Capital plc
is 588,110,974. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 (as in force in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018).
For further information, please visit www.dukemountcapitalplc.com or contact:
| Dukemount Capital Plc | |
| Geoffrey Dart / Paul Gazzard | |
| Media Enquries |
|
| Miriad Media, Zak Mir | Tel: +44 (0)7867 527 659 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.